Aurisco Pharmaceutical Co.,Ltd.

SSE:605116.SS

21.07 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Omzet 401.995387.419355.939394.01335.623340.002369.879250.514302.136239.118260.021290.104218.833214.278187.311215.446186.328177.851160.908201.967180.713144.118150.508
Kosten van de omzet 157.849156.866140.629165.909155.458147.314131.775112.986164.483101.421139.241149.97897.036108.76183.507109.764106.613112.44776.701101.55889.83161.76372.775
Brutowinst 244.146230.552215.31228.101180.165192.688238.103137.528137.653137.697120.78140.125121.798105.516103.804105.68379.71565.40484.208100.40990.88382.35577.734
Brutowinstmarge 0.6070.5950.6050.5790.5370.5670.6440.5490.4560.5760.4640.4830.5570.4920.5540.4910.4280.3680.5230.4970.5030.5710.516
Onderzoek- en ontwikkelingskosten 32.08740.9739.9333.3928.93241.10139.87230.19625.71736.07325.6923.31832.18228.53712.8516.31611.64816.3979.44911.5649.94417.7615.039
Algemene en administratieve kosten 40.866-51.78789.332-5.97937.342-50.0784.759-1.3237.864-36.67768.479-10.49328.877-32.51558.065-8.04223.846-30.51222.662-7.91316.527-28.85722.516
Verkoop- en marketingkosten 29.2148.69234.28144.85224.12933.53541.3815.1310.73211.2399.04810.3129.2648.0137.2197.9286.54-3.8195.1969.2910.6811.7594.793
Verkoop-, algemene en administratieve kosten 70.08-43.094123.61386.40661.472-16.535126.13913.8148.596-25.43877.526-0.18138.141-24.50365.285-0.11430.385-34.33127.8591.37627.206-17.09827.31
Overige kosten 0.44148.254-55.010.138-1.341-1.1161.939-2.241-0.59186.93-35.65935.673-2.209-0.161-1.085-0.106-0.2570.06-0.102-1.095-0.39637.275-1.673
Bedrijfskosten 102.608146.13108.534119.79692.145124.863120.57590.19273.72297.56667.55858.8168.11367.43648.26350.16436.57731.05638.79737.74234.53942.56732.712
Bedrijfsresultaat 141.53884.423113.342108.305100.44965.395147.36958.9958.97325.57325.23494.02453.42538.39656.66858.12640.43123.6440.65963.7159.26232.2254.599
Bedrijfsresultaat ratio 0.3520.2180.3180.2750.2990.1920.3980.2350.1950.1070.0970.3240.2440.1790.3030.270.2170.1330.2530.3150.3280.2240.363
Totaal overige inkomsten en kosten netto -0.002-1.612-5.1320.138-1.341-1.116-0.279-0.023-0.2290.004-0.125-0.355-0.048-0.161-1.085-0.106-0.2570.06-0.102-1.095-0.39637.275-1.673
Inkomen voor belasting 141.53682.81108.21117.26399.10864.279147.0958.96658.74525.57768.1393.66953.37738.23555.58358.0240.17423.740.55762.61658.86669.49552.927
Inkomen voor belasting ratio 0.3520.2140.3040.2980.2950.1890.3980.2350.1940.1070.2620.3230.2440.1780.2970.2690.2160.1330.2520.310.3260.4820.352
Belastingkosten 22.11811.81313.00710.85616.9247.93811.217.82813.0343.047-1.37618.02912.8413.0595.4547.6167.6016.6783.4159.568.8593.2395.089
Nettowinst 119.41870.99795.203106.40882.18456.873136.6550.01945.87824.50169.65675.88640.85335.19850.53950.40432.57317.02237.14253.05550.00866.25647.838
Nettowinstmarge 0.2970.1830.2670.270.2450.1670.3690.20.1520.1020.2680.2620.1870.1640.270.2340.1750.0960.2310.2630.2770.460.318
WPA (Winst Per Aandeel) 0.30.1780.240.260.20.470.340.120.110.0610.170.190.10.090.120.120.080.0460.10.150.140.180.13
Verwaterde WPA 0.30.1780.240.260.20.470.340.120.110.0610.170.190.10.090.120.120.080.0460.10.150.140.180.13
EBITDA 149.6992.407113.378139.897121.9185.143168.42579.5579.12753.54385.87111.32871.23354.77871.48270.22252.37734.34845.41173.19758.19239.78852.927
EBITDA ratio 0.3720.2390.3190.3550.3630.250.4550.3180.2620.2240.330.3840.3260.2560.3820.3260.2810.1930.2820.3620.3220.2760.352